Analysts Offer Predictions for Cardinal Health, Inc.’s Q4 2026 Earnings (NYSE:CAH)

Cardinal Health, Inc. (NYSE:CAHFree Report) – Research analysts at Zacks Research upped their Q4 2026 earnings estimates for Cardinal Health in a report released on Tuesday, October 1st. Zacks Research analyst R. Department now forecasts that the company will earn $2.48 per share for the quarter, up from their prior estimate of $2.47. The consensus estimate for Cardinal Health’s current full-year earnings is $7.62 per share. Zacks Research also issued estimates for Cardinal Health’s FY2027 earnings at $8.62 EPS.

Cardinal Health (NYSE:CAHGet Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported $1.84 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.10. Cardinal Health had a net margin of 0.37% and a negative return on equity of 54.85%. The business had revenue of $59.87 billion during the quarter, compared to the consensus estimate of $58.74 billion. During the same quarter in the prior year, the firm posted $1.55 earnings per share. The company’s revenue was up 12.1% compared to the same quarter last year.

Several other research analysts also recently weighed in on the company. Morgan Stanley upped their target price on Cardinal Health from $114.00 to $119.00 and gave the stock an “overweight” rating in a research note on Thursday, August 15th. UBS Group increased their price objective on shares of Cardinal Health from $120.00 to $125.00 and gave the company a “buy” rating in a report on Thursday, August 15th. JPMorgan Chase & Co. upped their price target on shares of Cardinal Health from $111.00 to $123.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Evercore ISI boosted their price objective on Cardinal Health from $105.00 to $115.00 and gave the stock an “in-line” rating in a research note on Thursday, August 15th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Cardinal Health from $115.00 to $119.00 and gave the company a “hold” rating in a research note on Friday, August 16th. One analyst has rated the stock with a sell rating, four have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $119.36.

Read Our Latest Research Report on CAH

Cardinal Health Trading Up 0.1 %

Shares of CAH stock opened at $110.33 on Thursday. Cardinal Health has a 12-month low of $86.70 and a 12-month high of $116.05. The business’s 50 day moving average is $107.96 and its two-hundred day moving average is $103.90. The company has a market capitalization of $26.87 billion, a P/E ratio of 49.04, a P/E/G ratio of 1.33 and a beta of 0.60.

Institutional Investors Weigh In On Cardinal Health

Several large investors have recently bought and sold shares of CAH. Park Avenue Securities LLC grew its position in shares of Cardinal Health by 17.7% during the third quarter. Park Avenue Securities LLC now owns 20,783 shares of the company’s stock worth $2,297,000 after buying an additional 3,126 shares in the last quarter. Czech National Bank raised its holdings in shares of Cardinal Health by 7.0% in the 3rd quarter. Czech National Bank now owns 49,673 shares of the company’s stock valued at $5,490,000 after purchasing an additional 3,259 shares in the last quarter. Park National Corp OH lifted its position in shares of Cardinal Health by 16.7% during the 3rd quarter. Park National Corp OH now owns 101,907 shares of the company’s stock worth $11,263,000 after purchasing an additional 14,563 shares during the last quarter. Mattson Financial Services LLC acquired a new position in shares of Cardinal Health during the second quarter worth $1,118,000. Finally, Paragon Capital Management Inc. increased its holdings in Cardinal Health by 0.7% in the second quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company’s stock valued at $1,451,000 after buying an additional 99 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Insiders Place Their Bets

In other news, insider Jessica L. Mayer sold 17,896 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total value of $1,905,566.08. Following the transaction, the insider now directly owns 94,529 shares in the company, valued at approximately $10,065,447.92. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CEO Jason M. Hollar sold 26,716 shares of the company’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $108.87, for a total transaction of $2,908,570.92. Following the sale, the chief executive officer now owns 244,091 shares of the company’s stock, valued at $26,574,187.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jessica L. Mayer sold 17,896 shares of Cardinal Health stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total value of $1,905,566.08. Following the completion of the transaction, the insider now owns 94,529 shares of the company’s stock, valued at $10,065,447.92. The disclosure for this sale can be found here. Insiders sold a total of 113,963 shares of company stock valued at $12,379,980 over the last 90 days. 0.15% of the stock is owned by company insiders.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st will be given a $0.506 dividend. The ex-dividend date is Tuesday, October 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.83%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is presently 89.78%.

Cardinal Health Company Profile

(Get Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Stories

Earnings History and Estimates for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.